MicroPort CardioFlow Medtech Corporation (Stock Code: 2160) published a notice of an Extraordinary General Meeting (EGM) scheduled for December 15, 2025, at 10:00 a.m. in Shanghai, China. The meeting aims to approve a merger agreement dated September 29, 2025, among the company, MicroPort CardioFlow CRM Limited (Merger Sub), and MicroPort Cardiac Rhythm Management Limited (Target Company), under Section 233 of the Cayman Companies Act.

The merger agreement proposes that, upon satisfaction or waiver of relevant conditions precedent, the company will allot and issue 3,953,847,407 new ordinary shares at HK$1.35 each to the Target Company’s shareholder. The EGM notice states that the company’s shareholders, whose names appear on the register of members before 4:30 p.m. on December 10, 2025, will be entitled to attend and vote. The register of members will be closed from December 10, 2025, through December 15, 2025 (both dates inclusive) for this purpose.

The board advises that all voting on relevant resolutions at the EGM will be taken by poll as required by the Listing Rules, and any results will be announced in accordance with standard regulatory procedures. Shareholders and authorized proxies must provide valid identity documents and make their own travel arrangements to attend. The record date for the meeting is December 15, 2025.